Similar articles for PMID: 15479682

Year	Number of Results
1963	1
1992	2
1997	1
1999	6
2000	2
2001	1
2003	2
2004	4
2005	5
2006	9
2007	6
2008	6
2009	7
2010	14
2011	9
2012	7
2013	10
2014	7
2015	5
2016	6
2017	4
2018	4
2019	4
2020	5
2021	7
2022	8
2023	2
2024	0

1

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J. Kruis W, et al. Gut. 2004 Nov;53(11):1617-23. doi: 10.1136/gut.2003.037747. Gut. 2004. PMID: 15479682 Free PMC article. Clinical Trial.

2

[Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].

Adam B, Liebregts T, Holtmann G. Adam B, et al. Z Gastroenterol. 2006 Mar;44(3):267-9. doi: 10.1055/s-2005-858972. Z Gastroenterol. 2006. PMID: 16514573 German. No abstract available.

3

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Rembacken BJ, et al. Lancet. 1999 Aug 21;354(9179):635-9. doi: 10.1016/s0140-6736(98)06343-0. Lancet. 1999. PMID: 10466665 Clinical Trial.

4

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

Kruis W, Schütz E, Fric P, Fixa B, Judmaier G, Stolte M. Kruis W, et al. Aliment Pharmacol Ther. 1997 Oct;11(5):853-8. doi: 10.1046/j.1365-2036.1997.00225.x. Aliment Pharmacol Ther. 1997. PMID: 9354192 Free article. Clinical Trial.

5

Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.

Langhorst J, Varnhagen I, Schneider SB, Albrecht U, Rueffer A, Stange R, Michalsen A, Dobos GJ. Langhorst J, et al. Aliment Pharmacol Ther. 2013 Sep;38(5):490-500. doi: 10.1111/apt.12397. Epub 2013 Jul 4. Aliment Pharmacol Ther. 2013. PMID: 23826890 Free article. Clinical Trial.

6

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, Gasbarrini A. Scaldaferri F, et al. World J Gastroenterol. 2016 Jun 28;22(24):5505-11. doi: 10.3748/wjg.v22.i24.5505. World J Gastroenterol. 2016. PMID: 27350728 Free PMC article. Review.

7

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

Kruis W, Kiudelis G, Rácz I, Gorelov IA, Pokrotnieks J, Horynski M, Batovsky M, Kykal J, Boehm S, Greinwald R, Mueller R; International Salofalk OD Study Group. Kruis W, et al. Gut. 2009 Feb;58(2):233-40. doi: 10.1136/gut.2008.154302. Epub 2008 Oct 2. Gut. 2009. PMID: 18832520 Free PMC article. Clinical Trial.

8

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.

Petersen AM, Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA. Petersen AM, et al. J Crohns Colitis. 2014 Nov;8(11):1498-505. doi: 10.1016/j.crohns.2014.06.001. Epub 2014 Jun 25. J Crohns Colitis. 2014. PMID: 24972748 Clinical Trial.

9

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.

Henker J, Müller S, Laass MW, Schreiner A, Schulze J. Henker J, et al. Z Gastroenterol. 2008 Sep;46(9):874-5. doi: 10.1055/s-2008-1027463. Epub 2008 Sep 22. Z Gastroenterol. 2008. PMID: 18810672

10

Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

Kruis W, Schreiber S, Theuer D, Brandes JW, Schütz E, Howaldt S, Krakamp B, Hämling J, Mönnikes H, Koop I, Stolte M, Pallant D, Ewald U. Kruis W, et al. Gut. 2001 Dec;49(6):783-9. doi: 10.1136/gut.49.6.783. Gut. 2001. PMID: 11709512 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year